The Therapeutic Goods
Administration has released further
details of the retail level recall
of Children’s Panadol 1-5 years
suspension (PD 02 Dec).
The two affected batches, in
which the paracetamol level does
not match the specification, were
dispatched from GSK between
September and November 2013,
and both have an expiry date of 31
March 2015.
The identified batches are
strawberry/200mL, batch number
130869, and orange/100mL, batch
number 130697.
No other Children’s Panadol
products are affected by the issue.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Dec 13
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.